Mainz, Germany

Maria Kreuzberg

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 9 EPO patents. Top assignees: Johannes Gutenberg-Universität Mainz, Ganymed Pharmaceuticals Ag, Ganymed Pharmaceuticals Gmbh. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Kreuzberg. Retrieved from https://idiyas.com/inventor/maria-kreuzberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 86.7

 

 

Average Co-Inventor Count = 7.4

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Aachen, DE (2023)
  • Mainz, DE (2016 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: **Maria Kreuzberg: Pioneering Cancer Therapeutics Through Innovative Antibodies**

Introduction

Maria Kreuzberg is a distinguished inventor based in Mainz, Germany, with an impressive portfolio of 15 patents to her name. Her groundbreaking work focuses primarily on the development of antibodies that target specific markers related to various forms of cancer. Kreuzberg's contributions to the field of biomedicine are significant, as she aims to create effective therapeutic options for patients suffering from different types of cancer.

Latest Patents

Among her latest patents are innovations related to antibodies for the treatment of cancers expressing claudin 6. These inventions provide critical tools for therapeutics aimed at treating and preventing diseases linked to cells that express the protein CLDN6. This includes a wide range of tumor-related diseases such as ovarian cancer, lung cancer, gastric cancer, breast cancer, and many others. Her work on antibodies specific for claudin 6 emphasizes the potential for targeted treatment strategies in oncology.

Career Highlights

Throughout her career, Maria Kreuzberg has made significant strides in the realm of cancer research. She has been associated with notable institutions such as Johannes Gutenberg University Mainz and Ganymed Pharmaceuticals AG, where she has honed her expertise in biopharmaceuticals. Her innovations demonstrate a commitment to advancing medical science and enhancing patient care through therapeutic development.

Collaborations

In her journey, Kreuzberg has not worked alone. She has collaborated with eminent figures in the scientific community, including Ugur Sahin and Korden Walter. These collaborations have enriched her research and allowed for a dynamic exchange of ideas, ultimately leading to impactful developments in the field.

Conclusion

Maria Kreuzberg's innovative contributions to cancer treatment exemplify the crucial role of inventors in advancing medical technology. With a robust collection of patents and a dedication to collaboration and research, she continues to inspire future advancements in the fight against cancer. Her work not only holds promise for better treatment options but also reinforces the importance of targeted therapies in modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…